Marker Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.13

-0.03 (-2.17%)

As of Sep 28, 10:34 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 8 89%

Hold 1 11%

Sell 0 0%

Price Target

Analyst Price Target +1,346.2% upside

Low Target $12.16

Average Target $16.27

High Target $21.27

Current Price $1.13

Current
$1.13

Target
$16.27

$12.16 $16.27 avg $21.27

Scenario Analysis

Bear Case

$12.16

980.9%

Low target

Base Case

$16.27

+1,346.2%

Avg target

Bull Case

$21.27

+1,790.7%

High target

Risk/Reward

1.8x

Balanced

Price in Context

52-Week High

$2.46

-54.3% from high

52-Week Low

$0.84

+33.9% from low

Target vs 52W High

$16.27

+561.4% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-2.2%
AMGN Amgen Inc	Hold	43	47%	$190.87	-54.5%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+140.7%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-16.6%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-89.8%
MRNA Moderna Inc	Hold	30	37%	$149.45	-24.8%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-65.2%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-43.5%